 double-blind comparison calcipotriol betamethason valer treatment psoriasi vulgari erratum lancet apr therapeut efficaci toler calcipotriol ointment betamethason valer ointment psoriasi multicentr prospect randomis double-blind right/left trial inpati outpati psoriasi vulgari symmetr distribut week calcipotriol ointment micrograms/g betamethason ointment side bodi main outcom measur psoriasi area sever index pasi investig assess erythema thick scale patient assess overal respons treatment week treatment pasi score investig assess score visit pasi score betamethason week mean pasi reduct calcipotriol betamethason confid interv differ score erythema thick betamethason end treatment patient calcipotriol-tr side betamethasone-tr side end treatment advers event patient common advers event lesional/perilesion skin irrit common calcipotriol treatment patient studi local advers event chang serum calcium studi thu calcipotriol ointment superior valer ointment psoriasi vulgari long-term result avail calcipotriol great promis antipsoriat agent